Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 22627104

Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2012 Jul
First author
Rödel C

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2012 Jul;13(7):651-3. doi: 10.1016/S1470-2045(12)70214-0.
    note
    Source null
    related pmid
    22627103
    relationship
    Comment in

Authors and identifiers

  1. name
    Rödel C
    type
    Author
  2. name
    Liersch T
    type
    Author
  3. name
    Becker H
    type
    Author
  4. name
    Fietkau R
    type
    Author
  5. name
    Hohenberger W
    type
    Author
  6. name
    Hothorn T
    type
    Author
  7. name
    Graeven U
    type
    Author
  8. name
    Arnold D
    type
    Author
  9. name
    Lang-Welzenbach M
    type
    Author
  10. name
    Raab HR
    type
    Author
  11. name
    Sülberg H
    type
    Author
  12. name
    Wittekind C
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Rödel C
    type
    Author
  2. name
    Liersch T
    type
    Author
  3. name
    Becker H
    type
    Author
  4. name
    Fietkau R
    type
    Author
  5. name
    Hohenberger W
    type
    Author
  6. name
    Hothorn T
    type
    Author
  7. name
    Graeven U
    type
    Author
  8. name
    Arnold D
    type
    Author
  9. name
    Lang-Welzenbach M
    type
    Author
  10. name
    Raab HR
    type
    Author
  11. name
    Sülberg H
    type
    Author
  12. name
    Wittekind C
    type
    Author
bibliography ids
  1. nci-bib-e00557bef087719721b9b495
book metadata
content sha256
fa89e24c80957eafcc533fd0eddf35a75f170503723840ec2e81ed9a8a098f8c
document type
citation
dois
  1. 10.1016/S1470-2045(12)70187-0
electronic publication date
display
2012 May 23
precision
day
year
2012
evidence scope
bibliographic_metadata_only
id
pubmed:22627104
immutable id
pubmed:22627104@fa89e24c80957eafcc533fd0eddf35a75f170503723840ec2e81ed9a8a098f8c
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
7
name
The Lancet. Oncology
nlm unique id
100957246
pages
679-87
volume
13
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2012 Jul;13(7):651-3. doi: 10.1016/S1470-2045(12)70214-0.
    note
    Source null
    related pmid
    22627103
    relationship
    Comment in
outcomes validated
false
pmid
22627104
provenance
batch id
c95be1d0b8cf19942816
provider
NCBI PubMed ESummary
record sha256
bb8c4e4c84d4f8a1a2f855e06aa28c93ecab24de52a020dd3babdf0181faf182
response sha256
a96bb680a8f3690267e009557d1b07aab71455ba44aeba18695d98a3eeb5fcf2
retrieved at
2026-09-09T23:46:47.691937+00:00
publication date
display
2012 Jul
precision
month
year
2012
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/22627104/
title
Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial.

Preserved source evidence · Independent clinical review pending · Not medical advice